Decarboxylases involved in polyamine biosynthesis and their inactivation by nitric oxide.

[1]  F. Murad,et al.  Novel effects of nitric oxide. , 2003, Annual review of pharmacology and toxicology.

[2]  Robert H. White,et al.  Methanococcus jannaschii Uses a Pyruvoyl-dependent Arginine Decarboxylase in Polyamine Biosynthesis* , 2002, The Journal of Biological Chemistry.

[3]  C. Klein.  Nitric oxide and the other cyclic nucleotide. , 2002, Cellular signalling.

[4]  Per-Ola Norrby,et al.  S-adenosylmethionine conformations in solution and in protein complexes: conformational influences of the sulfonium group. , 2002, Biochemistry.

[5]  L. Rudolph-Owen,et al.  Cloning of human agmatinase. An alternate path for polyamine synthesis induced in liver by hepatitis B virus. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[6]  G. Murphy,et al.  Long-range interactions in the dimer interface of ornithine decarboxylase are important for enzyme function. , 2001, Biochemistry.

[7]  L. Ignarro,et al.  Role of p42/p44 mitogen-activated-protein kinase and p21waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  W. Tolbert,et al.  Structure of a human S-adenosylmethionine decarboxylase self-processing ester intermediate and mechanism of putrescine stimulation of processing as revealed by the H243A mutant. , 2001, Biochemistry.

[9]  S E Ealick,et al.  The structural basis for substrate specificity and inhibition of human S-adenosylmethionine decarboxylase. , 2001, Biochemistry.

[10]  P. Coffino,et al.  Antizyme, a mediator of ubiquitin-independent proteasomal degradation. , 2001, Biochimie.

[11]  P. Woster,et al.  Terminally alkylated polyamine analogues as chemotherapeutic agents. , 2001, Journal of medicinal chemistry.

[12]  E. Goldsmith,et al.  Altering the reaction specificity of eukaryotic ornithine decarboxylase. , 2000, Biochemistry.

[13]  S. Cederbaum,et al.  Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. , 2000, Cancer research.

[14]  D. Reis,et al.  Characterization of Arginine Decarboxylase in Rat Brain and Liver , 2000, Journal of neurochemistry.

[15]  N. Grishin,et al.  Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding. , 2000, Journal of molecular biology.

[16]  A. Pegg,et al.  Mechanistic Studies of the Processing of Human S-Adenosylmethionine Decarboxylase Proenzyme , 1999, The Journal of Biological Chemistry.

[17]  N. Grishin,et al.  X-ray structure of ornithine decarboxylase from Trypanosoma brucei: the native structure and the structure in complex with alpha-difluoromethylornithine. , 1999, Biochemistry.

[18]  L. Ignarro,et al.  Nitric oxide inhibits ornithine decarboxylase by S-nitrosylation. , 1999, Biochemical and biophysical research communications.

[19]  A. Kern,et al.  Structure of mammalian ornithine decarboxylase at 1.6 A resolution: stereochemical implications of PLP-dependent amino acid decarboxylases. , 1999, Structure.

[20]  I. Mathews,et al.  The crystal structure of human S-adenosylmethionine decarboxylase at 2.25 A resolution reveals a novel fold. , 1999, Structure.

[21]  A. Pegg,et al.  Role of cysteine-82 in the catalytic mechanism of human S-adenosylmethionine decarboxylase. , 1999, Biochemistry.

[22]  L. Shantz,et al.  Expression of an ornithine decarboxylase dominant-negative mutant reverses eukaryotic initiation factor 4E-induced cell transformation. , 1996, Cancer research.

[23]  A. Pegg,et al.  Rapid exchange of subunits of mammalian ornithine decarboxylase. , 1994, The Journal of biological chemistry.

[24]  A. Pegg,et al.  Spermidine/spermine N1‐acetyltransferase — the turning point in polyamine metabolism , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  L. Shantz,et al.  Purification of human S-adenosylmethionine decarboxylase expressed in Escherichia coli and use of this protein to investigate the mechanism of inhibition by the irreversible inhibitors, 5'-deoxy-5'-[(3-hydrazinopropyl)methylamino]adenosine and 5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosin , 1992, Biochemistry.

[26]  A. Pegg,et al.  Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alpha-difluoromethylornithine. Characterization of sequences at the inhibitor and coenzyme binding sites. , 1992, The Journal of biological chemistry.

[27]  A. Pegg,et al.  Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. , 1988, Cancer research.

[28]  A. Pegg,et al.  Acetylation of decarboxylated S-adenosylmethionine by mammalian cells. , 1986, Biochemistry.

[29]  A. Pegg.  The role of polyamine depletion and accumulation of decarboxylated S-adenosylmethionine in the inhibition of growth of SV-3T3 cells treated with alpha-difluoromethylornithine. , 1984, The Biochemical journal.

[30]  Aled Edwards,et al.  The crystal structure of spermidine synthase with a multisubstrate adduct inhibitor , 2002, Nature Structural Biology.

[31]  Seymour S. Cohen.  A Guide to the Polyamines , 1998 .

[32]  L. Marton,et al.  Polyamines as targets for therapeutic intervention. , 1995, Annual review of pharmacology and toxicology.

[33]  P. McCann,et al.  S-adenosylmethionine decarboxylase as an enzyme target for therapy. , 1992, Pharmacology & therapeutics.